Methylprednisolone in adults hospitalized with COVID-19 pneumonia : An open-label randomized trial (GLUCOCOVID).
Luis Corral GudinoAlberto BahamondeFrancisco Arnaiz-RevillasJulia Gómez-BarqueroJesica Abadía-OteroCarmen García-IbarbiaVíctor MoraAna Cerezo-HernándezJosé L HernándezGraciela López-MuñízFernando Hernández-BlancoJose M CifriánJose M OlmosMiguel CarrascosaLuis NietoMaría Carmen FariñasJose A Rianchonull nullPublished in: Wiener klinische Wochenschrift (2021)
The planned sample size was not achieved, and our results should therefore be interpreted with caution. The use of MP had no significant effect on the primary endpoint in ITT analysis; however, the PP analysis showed a beneficial effect due to MP, which consistent with other published trials support the use of glucocorticoids in severe cases of COVID-19.